Business
MDA Ltd. Completes Initial Public Offering
MDA Ltd. Completes Initial Public Offering Canada NewsWire /NOT FOR D...
About this update from Mda Space Ltd
[{"type":"text","content":"\n \n \n \n MDA Ltd. Completes Initial Public Offering\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n /NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN\n \n THE UNITED STATES\n \n /\n \n \n \n \n BRAMPTON, ON\n \n ,\n \n April 7, 2021\n \n /CNW/ - MDA Ltd. (\"\n \n MDA\n \n \" or the \"\n \n Company\n \n \"), a leading provider of advanced technology and services to the burgeoning global space industry, today announced the successful closing of its previously announced initial public offering of common shares (the \"\n \n Common Shares\n \n \") of the Company (the \"\n \n Offering\n \n \"). Pursuant to the Offering, MDA issued 28,571,500 Common Shares at a price of\n \n $14.00\n \n per Common Share for gross proceeds to the Company of approximately\n \n $400 million\n \n .\n \n \n \n \n \n \n \n \n \n The Common Shares are listed on the Toronto Stock Exchange under the symbol \"MDA\".\n \n \n The Offering was made through a syndicate of underwriters led by BMO Capital Markets, Morgan Stanley Canada Limited and Scotiabank, as joint bookrunners, with Barclays Capital Canada Inc., RBC Dominion Securities Inc., Canaccord Genuity Corp., CIBC World Markets Inc., National Bank Financial Inc. and Stifel Nicolaus Canada Inc., as underwriters.\n \n \n Goodmans LLP and Skadden, Arps, Slate, Meagher & Flom LLP acted as legal counsel to the Company, and\n \n Osler\n \n , Hoskin & Harcourt LLP and Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as legal counsel to the underwriters.\n \n \n The Company has granted to the underwriters an option, exercisable, in whole or in part, at any time and from time to time for a period of 30 days after closing of the Offering, to purchase from the Company up to 4,285,725 Common Shares (representing 15% of the number of Common Shares sold in the base offering) at a price of\n \n $14.00\n \n per Common Share, for the purpose of covering the underwriters' over-allocation position, if any.\n \n \n No securities regulatory authority has eith...